LTRN
Lantern Pharma Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.91
+1.87%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
579.8%
Return on equity
-216.8%
Return on assets
486.7%
Return on invested capital
0.00x
Asset turnover
-$14.1M
Cash from operations
$0.58
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026